A comparative evaluation of risk communication formats in cancer prevention

癌症预防中风险沟通形式的比较评估

基本信息

  • 批准号:
    7643997
  • 负责人:
  • 金额:
    $ 14.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Effective communication about possible risks and benefits of medical interventions to patients has been an integral part of medical care since the doctrine of informed consent was adopted. In recent years, it has become increasingly more important due to changes in the accepted model of the doctor-patient relationship that promote more active involvement of patients in decisions about their care, the rise of evidence-based medical practice, and the increasing emphasis placed on preventive measures that are intended to reduce future health risks. Effective communication about the possible outcomes of medical interventions is also an essential component of methods for improving the translation of biomedical research findings into practice. Despite its importance, there are large gaps in our knowledge of how to effectively convey information about uncertain future events to patients and practitioners. The specific aims of this study are: 1) To provide initial estimates differences among currently recommended numeric and graphic formats in their ability to convey information to patients about possible outcomes that vary across a representative range of clinically important likelihoods and consequences; 2) To provide initial estimates of interactions between the effectiveness of the risk communication formats and patient characteristics including: numeracy, literacy, educational level, socio- economic status, age, and racial/ethnic background; and 3) To develop an analytic framework and to gather data about key parameters for use in planning and conducting a follow-up R01-level study that will thoroughly address these issues. The patient population will consist of demographically-stratified sample of 360 patients at least 18 years of age who are patients at three outpatient practices in Rochester New York. An incomplete factorial design with two five-level within-subject factors will be used. One factor will be five currently recommended risk communication formats: vertical bar charts, grouped icon displays, risk scales, frequency diagrams, and numeric frequency information. The other factor will be five outcomes of a disease screening program: risk of disease, risk of dying from disease, risk of a serious screening side effect, risk of dying from a screening side effect, and risk of a false positive screening test result. Each subject will be randomly assigned to respond to risk information in five of the possible 25 combinations such that they are presented with each risk outcome and each risk format in some combination. To facilitate the design of a future comprehensive R01-level study, data from this study will be used to gain initial estimates of risk format and subject variables on the differences among the five risk presentation formats on the following outcomes: a) comprehension, b) usefulness for decision making, c) hazard-response consistency, d) uniformity, e) patient evaluation, and f) direction of communication errors. We will also determine if there are associations between these outcomes and either the nature of the risk or individual patient characteristics including demographics, education, literacy, and numeracy. PUBLIC HEALTH RELEVANCE: Effective communication about possible risks and benefits of medical interventions is essential for ensuring the delivery of consistently high quality health care. Despite its importance, there are large gaps in our knowledge of how to effectively convey information about uncertain future outcomes of health care decisions to patients and practitioners. This project will begin to address these gaps by: a) comparing how well five currently recommended risk communication formats convey risk information to patients across a range of clinically important probabilities and outcomes, and b) determining whether patient characteristics such as demographics, numeracy, and literacy affect the effectiveness of health risk communications.
说明(由申请人提供):自采用知情同意原则以来,关于医疗干预对患者可能带来的风险和益处的有效沟通一直是医疗护理的一个组成部分。近年来,由于公认的医患关系模式发生了变化,促使患者更积极地参与有关其护理的决策,循证医学实践的兴起,以及旨在减少未来健康风险的预防措施日益受到重视,因此,它变得越来越重要。关于医疗干预可能结果的有效沟通也是改进将生物医学研究成果转化为实践的方法的重要组成部分。尽管它很重要,但在如何有效地向患者和从业者传达有关不确定未来事件的信息方面,我们的知识存在很大差距。本研究的具体目的是:1)提供目前推荐的数字和图形格式在向患者传达可能结果的能力方面的初步估计差异,这些信息在具有代表性的临床重要可能性和后果范围内变化;2)提供风险沟通形式的有效性与患者特征(包括:计算能力、读写能力、教育水平、社会经济地位、年龄和种族/民族背景)之间相互作用的初步估计;3)制定分析框架并收集关键参数数据,用于规划和开展后续r01级研究,以彻底解决这些问题。患者人群将由人口统计学上分层的360例患者组成,这些患者年龄至少为18岁,是纽约州罗切斯特市三家门诊诊所的患者。采用不完全因子设计,包括两个受试者内的五水平因子。其中一个因素是目前推荐的五种风险沟通格式:垂直条形图、分组图标显示、风险等级、频率图和数字频率信息。另一个因素是疾病筛查项目的五个结果:患病风险,死于疾病的风险,严重筛查副作用的风险,死于筛查副作用的风险,以及筛查结果假阳性的风险。每个受试者将被随机分配对25种可能组合中的5种风险信息作出反应,这样他们就会看到每种风险结果和某种组合中的每种风险形式。为了便于未来综合r01水平研究的设计,本研究的数据将用于获得风险格式和受试者变量对以下结果的差异的初步估计:a)理解,b)决策有用性,c)危害反应一致性,d)均匀性,e)患者评价,f)沟通错误方向。我们还将确定这些结果与风险性质或个体患者特征(包括人口统计学、教育、识字和计算能力)之间是否存在关联。公共卫生相关性:就医疗干预措施可能带来的风险和益处进行有效沟通,对于确保始终如一地提供高质量的卫生保健至关重要。尽管它很重要,但在如何有效地向患者和从业人员传达有关医疗保健决策不确定未来结果的信息方面,我们的知识存在很大差距。本项目将开始通过以下方式解决这些差距:a)比较目前推荐的五种风险沟通格式在一系列临床重要概率和结果方面向患者传达风险信息的情况;b)确定患者特征(如人口统计学、计算能力和读写能力)是否影响健康风险沟通的有效性。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
How Well Do Commonly Used Data Presentation Formats Support Comparative Effectiveness Evaluations?
  • DOI:
    10.1177/0272989x12445284
  • 发表时间:
    2012-11-01
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Dolan, James G.;Qian, Feng;Veazie, Peter J.
  • 通讯作者:
    Veazie, Peter J.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James G Dolan其他文献

Optimal management of adults with pharyngitis – a multi-criteria decision analysis

James G Dolan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James G Dolan', 18)}}的其他基金

Multi-criteria Clinical Decision Support: A Comparative Evaluation
多标准临床决策支持:比较评估
  • 批准号:
    8075585
  • 财政年份:
    2009
  • 资助金额:
    $ 14.5万
  • 项目类别:
Multi-criteria Clinical Decision Support: A Comparative Evaluation
多标准临床决策支持:比较评估
  • 批准号:
    8272553
  • 财政年份:
    2009
  • 资助金额:
    $ 14.5万
  • 项目类别:
Multi-criteria Clinical Decision Support: A Comparative Evaluation
多标准临床决策支持:比较评估
  • 批准号:
    7661786
  • 财政年份:
    2009
  • 资助金额:
    $ 14.5万
  • 项目类别:
Multi-criteria Clinical Decision Support: A Comparative Evaluation
多标准临床决策支持:比较评估
  • 批准号:
    8485637
  • 财政年份:
    2009
  • 资助金额:
    $ 14.5万
  • 项目类别:
A comparative evaluation of risk communication formats in cancer prevention
癌症预防中风险沟通形式的比较评估
  • 批准号:
    7530014
  • 财政年份:
    2008
  • 资助金额:
    $ 14.5万
  • 项目类别:
Colorectoral cancer screening decisions in primary care
初级保健中的结直肠癌筛查决策
  • 批准号:
    6964855
  • 财政年份:
    2005
  • 资助金额:
    $ 14.5万
  • 项目类别:
Colorectoral cancer screening decisions in primary care
初级保健中的结直肠癌筛查决策
  • 批准号:
    7128141
  • 财政年份:
    2005
  • 资助金额:
    $ 14.5万
  • 项目类别:
THE ROLE OF ENDOSCOPY IN UPPER GASTROINTESTINAL BLEEDING
内窥镜检查在上消化道出血中的作用
  • 批准号:
    3372001
  • 财政年份:
    1991
  • 资助金额:
    $ 14.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 14.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 14.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 14.5万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 14.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 14.5万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 14.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了